Abemaciclib
Back to searchMolecule Structure
Scientific Name
Abemaciclib
Description of the Drug
Abemaciclib is a medication used to treat HR+ HER2- advanced or metastatic breast cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12001
http://www.drugbank.ca/drugs/DB12001
Brand Name(s)
Verzenio, Verzenios
Company Owner(s)
Eli Lilly And Co
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cyclin-dependent kinase 4 | SINGLE PROTEIN | INHIBITOR | CHEMBL331 |
Cyclin-dependent kinase 6 | SINGLE PROTEIN | INHIBITOR | CHEMBL2508 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2487229 | |
PharmGKB | PA166153471 | |
Human Metabolome Database | HMDB0247749 | |
DrugBank | DB12001 | |
PubChem: Thomson Pharma | 96075034 | |
PubChem | 46220502 | |
LINCS | LSM-46168 | LSM-46205 |
Nikkaji | J3.307.988E | |
PDBe | 6ZV | |
BindingDB | 50110183 | |
EPA CompTox Dashboard | DTXSID20673119 | |
DrugCentral | 5259 | |
ChemicalBook | CB72624906 | |
Guide to Pharmacology | 7382 | |
rxnorm | ABEMACICLIB | VERZENIO |
ZINC | ZINC000072318121 |